Upfront docetaxel for castration-sensitive metastatic prostate cancer in an ethnically diverse inner-city population.

Surabhi Pathak,Romy Jose Thekkekara,Ahmed T Ahmed,Udit Yadav,Michael Russell Mullane,Kumar Kunnal Batra,Thomas E. Lad,Sarah P. Psutka

Upfront docetaxel for castration-sensitive metastatic prostate cancer in an ethnically diverse inner-city population.

2018

Surabhi Pathak
Romy Jose Thekkekara
Ahmed T Ahmed
Udit Yadav
Michael Russell Mullane
Kumar Kunnal Batra
Thomas E. Lad
Sarah P. Psutka

e17038Background: Upfront docetaxel (UD) in castration-sensitive metastatic prostate cancer (CSPC) has improved failure-free and overall survival in the CHAARTED, GETUG-AFU 15 and STAMPEDE trials, ...

Keywords:

Prostate cancer
Pathology
Oncology
Castration
Internal medicine
Medicine
Docetaxel
Population
ethnically diverse
overall survival
inner city

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations